Upperton Pharma Solutions

Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development and clinical trial manufacturing services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing.

We enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular, we have world-leading expertise and know-how in pharmaceutical spray drying, with our founder having extensive expertise in this area.

We have a long history of working with oral, nasal, pulmonary and parenteral dosage forms, with a new Annex 1 aligned sterile facility due to open in 2026, and an existing GMP facility with state of the art equipment.

Upperton has a multinational client base, ranging from virtual and small start-up biotechs to global pharma companies. We pride ourselves on our client-focused, collaborative way of working, in addition to our flexible approach and scientific excellence.